The emerging approach of this peptide represents a major breakthrough in the care of diabetes mellitus type 2. Different to existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide306260.ja-blog.com/42334514/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment